• SENSEX 73,246.03
    -352.64 (--0.48%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
Back

Corporate News

Vivanza Biosciences to review quarterly and half-year financials at November 3 meeting
28-Oct-2026, 04:13

Vivanza Biosciences Limited will hold a meeting of its Board of Directors on November 3, 2026, at 3:30 P.M. to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, along with a limited review report. The company has closed the trading window for directors, officers, key managerial personnel, and designated persons until 48 hours after the unaudited financial results are declared.